News
1 October 2026
Fonko Strengthens Indonesia’s Oncology Industry Capacity
JAKARTA — PT Fonko International Pharmaceuticals has recorded several key milestones in the development of oncology drug manufacturing in Indonesia. These achievements include securing European Union Good Manufacturing Practice (EU GMP) certification in 2025, developing a range of "first copy" products for cancer therapy, and obtaining halal certification for its…
25 September 2026
Consistently Maintaining Halal Standards, Dexa Group Wins IHYA 2026
TANGERANG — PT Ferron Par Pharmaceuticals, a member of Dexa Group, has won the 2026 Indonesia Halal Industry Award (IHYA) from the Ministry of Industry of the Republic of Indonesia in the Large Industrial Enterprise Category, Subcategory of Best Pharmaceuticals and Traditional Medicines. This award recognizes Dexa Group’s consistency in…
24 September 2026
From Medications to Facilities, Ferron Strengthens Support for Cancer Patients
JAKARTA — Indonesia recorded 474,083 new cases and 283,299 deaths due to cancer, according to 2024 Global Cancer Observatory (GLOBOCAN) data. This situation underscores the critical role of Ferron Par Pharmaceuticals in expanding its support for cancer patients—from delivering access to medications to strengthening chemotherapy support facilities through the provision…
12 July 2019
Dexa Medica Brings Home Its 2nd Indonesia Public Relations Award
Towards the 50th anniversary of Dexa Group, PT Dexa Medica has won the Corporate PR Award (IPRA) 2019 for 2 consecutive years. The award, which was previously obtained in 2018 is an acknowledgment to the performance of Dexa Medica’s Corporate Public Relations. This award was presented by Warta Ekonomi…
26 June 2019
Boska Earns the Outstanding OTC Pharmaceutical Brand of The Year in Nigeria
Approaching Dexa Group’s 50-year dedication in the pharmaceutical and health industry, BOSKA has taken home the Outstanding OTC Pharmaceutical Brand of The Year award at the Marketing Edge Awards 2019 which was held at the Balmoral Event Center Oregun, Ikeja, Lagos, Nigeria, on Wednesday, 26 June 2019. This prestigious award…
27 May 2019
Dexa Medica Achieves IMACO Award 2019
Approaching Dexa Group’s 50-year anniversary, PT Dexa Medica was given the title of Excellent in Research and Development of Modern Medicine at the Indonesia Most Admired Companies (IMACO) Award 2019 from Warta Ekonomi. The award validates PT Dexa Medica as one of the leading national pharmaceutical companies in Indonesia, highlighting…
27 May 2019
STIMUNO Wins the Tenth Top Brand for Kids
Dexa Group received another special recognition following its 50th anniversary in the health industry. STIMUNO, the company’s product which is the only phytopharmaceutical immunomodulator in Indonesia, has won the Top Brand for Kids Award 2019 in the Child Immune System Vitamin category for the 10th year in a row since…
27 March 2019
Dexa Group Receives CSR Award from Bekasi Regency Government
Dexa Group received the Corporate Social Responsibility (CSR) award from the Bekasi Regency Government for the CSR programs carried out by Dharma Dexa. The award was presented by the Acting Regent of Bekasi, Eka Supria Atmaja to the Head of Corporate Communications Dexa Group, Sonny Himawan at the Coordination Meeting…
20 March 2019
STIMUNO Wins WOW Brand Award 2019
STIMUNO received the WOW Brand 2019 award from the survey agency MarkPlus Insight for its consistency of being the most recommended immunomodulator brand to family, relatives, and friends for the last 20 years. Dexa's Consumer Health Group Brand Manager, Theodorus Sugiarto Halim received the award at the Indonesia WOW Brand…
18 December 2018
Dexa Group CEO Named 2018 Most Admired CEO
Dexa Group CEO, Ferry A. Soetikno received the Indonesia Most Admired CEO Award 2018 on Friday, December 14, 2018 for the category of Excellent Leadership for Supporting Government Health Programs. The award recognizes Dexa Group's commitment to support the government's health programs through the innovation and production of best quality…